Noninvasive Evaluation for Congenital Arteriovenous Fistulas and Malformations

2012 ◽  
pp. 407-416 ◽  
Author(s):  
Robert B. Rutherford
1979 ◽  
Author(s):  
F Albert ◽  
U Schmidt

The effect of sulfinpyrazone (200 mg three times a day) and acetylsalicylic acid (500 mg three times a day) on the incidence of thrombosis of arteriovenous shunts was investigated in a controlled clinical trial. In 36 patients with chronic renal failure scheduled to begin haemodialysis the same operating team constructed a subcutaneous fistula in the distal forearm. During the first six weeks after the operation the antithrombotic efficacy proved to be good for both substances. No differences of thrombotic events between the two treatment groups were statistically significant. But in contrast to acetylsalicylic acid sulfinpyrazone made no significant inhibition of platelet - aggregation; sulfinpyrazone probably will prevent the clot formation by prolonging the shortened platelet survival in uraemic patients. In a high rate of patients given acetylsalicylic acid (10 out of 17) there were local bleeding and gastrointestinal side effects. In consequence we should prefer sulfinpyrazone, because in the sulfinpyrazone group side effects were minimal and in none patient withdrawal from the study was necessitated.


Skull Base ◽  
2005 ◽  
Vol 15 (S 2) ◽  
Author(s):  
Wuttipong Tirakotai ◽  
C. Kappus ◽  
B. Krischek ◽  
U. Sure ◽  
H. Bertalanffy

2004 ◽  
Vol 51 (6) ◽  
pp. 609
Author(s):  
Young Sun Lee ◽  
Gong Yong Jin ◽  
Young Min Han ◽  
Sang Yong Lee ◽  
Hak Hun Park ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document